The study and its comparison
A randomized trial included 121 participants. The study population was patients undergoing coronary artery bypass grafting. Researchers compared curcuminoids 4 g daily versus placebo, with follow-up over three days before through five days after surgery. [1]
In-hospital myocardial infarction occurred in 13.1% of the curcuminoid group and 30.0% of controls. The adjusted hazard ratio was 0.35, with a confidence interval from 0.13 to 0.95. [1]
What the finding establishes
The selected surgical population, limited size and short treatment window restrict generalization. The result does not establish that turmeric prevents ordinary heart attacks or lowers blood pressure. Perioperative use was supervised within a trial, so its regimen is not a reason to start supplements independently before surgery. Funding and complete conflicts were not established from the retrieved abstract. [1]
A hypothetical distinction
Imagine a benefit is measured during a hospital admission. It does not automatically establish long-term prevention after discharge.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Effects of curcuminoids on frequency of acute myocardial infarction after coronary artery bypass grafting.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.